|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"goldman j w"
Showing items 1-10 of 13 (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page
| 國立成功大學 |
2023 |
Three-Year Safety, Tolerability, and Health-Related Quality of Life Outcomes of Adjuvant Osimertinib in Patients With Resected Stage IB to IIIA EGFR-Mutated NSCLC: Updated Analysis From the Phase 3 ADAURA Trial
|
John, T.;Groh�, C.;Goldman, J.W.;Shepherd, F.A.;de, Marinis F.;Kato, T.;Wang, Q.;Su, W.-C.;Choi, J.H.;Sriuranpong, V.;Melotti, B.;Fidler, M.J.;Chen, J.;Albayaty, M.;Stachowiak, M.;Taggart, S.;Wu, Y.-L.;Tsuboi, M.;Herbst, R.S.;Majem, Majem M. |
| 國立成功大學 |
2023 |
Phase Ib Study of Telisotuzumab Vedotin in Combination With Erlotinib in Patients With c-Met Protein-Expressing Non-Small-Cell Lung Cancer
|
Camidge, D.R.;Barlesi, F.;Goldman, J.W.;Morgensztern, D.;Heist, R.;Vokes, E.;Spira, A.;Angevin, E.;Su, W.-C.;Hong, D.S.;Strickler, J.H.;Motwani, Motwani M.;Dunbar, M.;Parikh, A.;Noon, E.;Blot, V.;Wu, J.;Kelly, Kelly K. |
| 國立成功大學 |
2023 |
Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC
|
Tsuboi, M.;Herbst, R.S.;John, T.;Kato, T.;Majem, Majem M.;Groh�, C.;Wang, J.;Goldman, J.W.;Lu, S.;Su, W.-C.;De, Marinis F.;Shepherd, F.A.;Lee, K.H.;Le, N.T.;Dechaphunkul, A.;Kowalski, D.;Poole, L.;Bolanos, A.;Rukazenkov, Y.;Wu, Y.-L. |
| 臺大學術典藏 |
2022-06-27T06:59:40Z |
Osimertinib in resected EGFR-mutated non–small-cell lung cancer
|
Wu Y.-L.; Tsuboi M.; He J.; John T.; Grohe C.; Majem M.; Goldman J.W.; Laktionov K.; Kim S.-W.; Kato T.; Vu H.-V.; Lu S.; Lee K.-Y.; Akewanlop C.; CHONG-JEN YU; de Marinis F.; Bonanno L.; Domine M.; Shepherd F.A.; Zeng L.; Hodge R.; Atasoy A.; Rukazenkov Y.; Herbst R.S. |
| 臺大學術典藏 |
2022-06-27T06:59:32Z |
A plain language summary of results from the ADAURA study: osimertinib after surgery for patients who have early-stage EGFR-mutated non-small cell lung cancer
|
Wu Y.-L.; Tsuboi M.; John T.; Grohe C.; Majem M.; Goldman J.W.; Laktionov K.; Kim S.-W.; Kato T.; Vu H.-V.; Lu S.; Lee K.-Y.; Akewanlop C.; CHONG-JEN YU; De Marinis F.; Bonanno L.; Domine M.; Shepherd F.A.; Zeng L.; Hodge R.; Atasoy A.; Rukazenkov Y.; Herbst R.S. |
| 臺大學術典藏 |
2022-06-27T06:59:30Z |
Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC
|
Wu Y.-L.; John T.; Grohe C.; Majem M.; Goldman J.W.; Kim S.-W.; Kato T.; Laktionov K.; Vu H.V.; Wang Z.; Lu S.; Lee K.Y.; Akewanlop C.; CHONG-JEN YU; de Marinis F.; Bonanno L.; Domine M.; Shepherd F.A.; Zeng L.; Atasoy A.; Herbst R.S.; Tsuboi M. |
| 臺大學術典藏 |
2022-06-27T06:59:29Z |
Health-Related Quality of Life Outcomes in Patients with Resected Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer Who Received Adjuvant Osimertinib in the Phase III ADAURA Trial
|
Majem M.; Goldman J.W.; John T.; Grohe C.; Laktionov K.; Kim S.-W.; Kato T.; Vu H.V.; Lu S.; Li S.; Lee K.Y.; Akewanlop C.; CHONG-JEN YU; de Marinis F.; Bonanno L.; Domine M.; Shepherd F.A.; Atagi S.; Zeng L.; Kulkarni D.; Medic N.; Tsuboi M.; Herbst R.S.; Wu Y.-L. |
| 臺大學術典藏 |
2021-05-02T03:29:23Z |
Osimertinib in resected EGFR-mutated non–small-cell lung cancer
|
Wu Y.-L.;Tsuboi M.;He J.;John T.;Grohe C.;Majem M.;Goldman J.W.;Laktionov K.;Kim S.-W.;Kato T.;Vu H.-V.;Lu S.;Lee K.-Y.;Akewanlop C.;Chong-Jen Yu;De Marinis F.;Bonanno L.;Domine M.;Shepherd F.A.;Zeng L.;Hodge R.;Atasoy A.;Rukazenkov Y.;Herbst R.S.; Wu Y.-L.; Tsuboi M.; He J.; John T.; Grohe C.; Majem M.; Goldman J.W.; Laktionov K.; Kim S.-W.; Kato T.; Vu H.-V.; Lu S.; Lee K.-Y.; Akewanlop C.; CHONG-JEN YU; de Marinis F.; Bonanno L.; Domine M.; Shepherd F.A.; Zeng L.; Hodge R.; Atasoy A.; Rukazenkov Y.; Herbst R.S. |
| 臺大學術典藏 |
2021-04-23T05:56:31Z |
Osimertinib in patients with epidermal growth factor receptor mutation-positive non-small-cell lung cancer and leptomeningeal metastases: The BLOOM study
|
Chih-Hsin Yang;Kim S.-W.;Kim D.-W.;Lee J.-S.;Cho B.C.;Ahn J.-S.;Lee D.H.;Kim T.M.;Goldman J.W.;Natale R.B.;Brown A.P.;Collins B.;Chmielecki J.;Vishwanathan K.;Mendoza-Naranjo A.;Ahn M.-J.; CHIH-HSIN YANG; Kim S.-W.; Kim D.-W.; Lee J.-S.; Cho B.C.; Ahn J.-S.; Lee D.H.; Kim T.M.; Goldman J.W.; Natale R.B.; Brown A.P.; Collins B.; Chmielecki J.; Vishwanathan K.; Mendoza-Naranjo A.; Ahn M.-J. |
| 臺大學術典藏 |
2020-05-25T07:35:14Z |
Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study
|
Yang J.C.-H.; Yang Z; Overend P; Kao S; Goldman J.W; Su W.-C; Natale R; Rabbie S; Harrop B; John T; Kim H.R; Chia-Chi Lin; Kim T.M; Ahn J.-S; Lee J.S; Kim S.-W; Cho B.C; Kim D.-W; Ahn M.-J |
Showing items 1-10 of 13 (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page
|
